SPR® Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. We are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach. The first product to be commercialized is the SMARTPATCH™ PNS System, which is a short-term, minimally invasive system that is simple to deliver and can be used for up to 30 days to stimulate electrically a peripheral nerve to relieve pain.

SPR Therapeutics was formed in January, 2010 as a portfolio company of NDI Medical, LLC, a privately-owned company. NDI is a medical technology company focused on the development and commercialization of neurostimulation based therapies and medical devices. NDI has developed a proprietary platform of neurostimulation medical devices for use in multiple therapies. In April of 2008, NDI sold its first portfolio company, the MEDSTIM™ Bladder Pacer System for treating urinary incontinence, to Medtronic for $42 million.

SPR Therapeutics is headquartered in Cleveland, Ohio, the nation’s center for neurostimulation research.